Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion.

黄褐斑 皮肤病科 医学 色素沉着 痤疮
作者
Bryan D. Sofen,Giselle Prado,Jason Emer
出处
期刊:PubMed 卷期号:21 (1): 1-7 被引量:66
链接
标识
摘要

Dyschromia is a leading cause for cosmetic consultation, especially in those with diverse skin types (mixture of ethnicities) and with the rise of non-core and untrained physicians performing cosmetic procedures. Melasma and post-inflammatory hyperpigmentation (PIH) account for the majority of cases and are characterized by pigmented macules and patches distributed symmetrically in sun-exposed areas of the forehead, cheeks, and chin in melasma, and irregularly in areas of inflammation or an inciting traumatic event with PIH. Treatment is challenging and focused on a variety of mechanisms to stop, hinder, and/or prevent steps in the pigment production (melanocytic hyperactivity) process, breaking down deposited pigment for internal removal or external release, exfoliating cells to enhance turnover, and decreasing inflammation. Topical lightening therapy in combination with sun protection is essential for potential improvement. The most commonly prescribed and researched topical lightening agents are hydroquinone (HQ), azelaic acid (AzA), and retinoids - although only HQ and a triple combination cream (Tri-Luma®; fluocinolone acetonide 0.01%, HQ 4%, tretinoin 0.05%) are US FDA-approved for "bleaching of hyperpigmented skin" (HQ) and "melasma" (Tri-Luma®). Numerous non-HQ brightening/lightening agents, including antioxidant and botanical cosmeceuticals, have recently flooded the market with improvements that claim less irritant potential, as well as avoiding the stigmata associated with HQ agents such as carcinogenesis and cutaneous ochronosis. Combining topical therapy with procedures such as chemical peels, intense pulsed light (IPL), fractional non-ablative lasers or radiofrequency, pigment lasers (microsecond, picosecond, Q-switched), and microneedling, enhances results. With proper treatment, melasma can be controlled, improved, and maintained; alternatively, PIH can be cured in most cases. Herein, we review treatments for both conditions and provide an opinion on proper management for enhanced results.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
jj824完成签到 ,获得积分10
1秒前
1秒前
1秒前
无限小霜发布了新的文献求助20
1秒前
2秒前
达瓦里氏完成签到 ,获得积分10
2秒前
三泥完成签到,获得积分10
3秒前
小白完成签到 ,获得积分10
4秒前
4秒前
ys完成签到,获得积分20
5秒前
ningning完成签到 ,获得积分10
5秒前
xdx完成签到 ,获得积分10
6秒前
安然发布了新的文献求助10
6秒前
华仔应助亮晶晶采纳,获得10
6秒前
橘子发布了新的文献求助10
6秒前
客厅狂欢完成签到,获得积分10
7秒前
晓先森完成签到,获得积分10
7秒前
7秒前
廖天佑完成签到,获得积分0
8秒前
11111发布了新的文献求助30
8秒前
8秒前
典雅的毛巾完成签到 ,获得积分10
8秒前
xiao发布了新的文献求助10
8秒前
8秒前
桐桐应助wu61采纳,获得10
9秒前
9秒前
xmhxpz发布了新的文献求助10
9秒前
wsg发布了新的文献求助10
11秒前
隐形的傲易完成签到 ,获得积分10
12秒前
Candy发布了新的文献求助10
12秒前
12秒前
轻舟完成签到,获得积分10
13秒前
若雪幽梦发布了新的文献求助10
13秒前
小白一号应助傲娇文博采纳,获得10
15秒前
轻舟发布了新的文献求助30
15秒前
完美世界应助ccc采纳,获得10
16秒前
安静明杰完成签到 ,获得积分10
16秒前
文静野狼应助you采纳,获得10
17秒前
18秒前
明理如凡完成签到,获得积分10
19秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Cognitive Paradigms in Knowledge Organisation 2000
Effect of reactor temperature on FCC yield 2000
Introduction to Spectroscopic Ellipsometry of Thin Film Materials Instrumentation, Data Analysis, and Applications 1800
How Maoism Was Made: Reconstructing China, 1949-1965 800
Barge Mooring (Oilfield Seamanship Series Volume 6) 600
Medical technology industry in China 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3312954
求助须知:如何正确求助?哪些是违规求助? 2945312
关于积分的说明 8524570
捐赠科研通 2621088
什么是DOI,文献DOI怎么找? 1433321
科研通“疑难数据库(出版商)”最低求助积分说明 664936
邀请新用户注册赠送积分活动 650325